Heartland Bank & Trust Co Buys Shares of 2,305 DaVita Inc. (NYSE:DVA)

Heartland Bank & Trust Co bought a new stake in DaVita Inc. (NYSE:DVA - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 2,305 shares of the company's stock, valued at approximately $353,000.

Several other institutional investors also recently modified their holdings of DVA. UMB Bank n.a. grew its holdings in shares of DaVita by 65.5% during the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after purchasing an additional 76 shares in the last quarter. Copia Wealth Management acquired a new stake in shares of DaVita during the 4th quarter worth approximately $30,000. SBI Securities Co. Ltd. acquired a new stake in shares of DaVita during the 4th quarter worth approximately $41,000. Coppell Advisory Solutions LLC grew its holdings in shares of DaVita by 50.0% during the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company's stock worth $45,000 after purchasing an additional 100 shares in the last quarter. Finally, Canada Post Corp Registered Pension Plan acquired a new stake in shares of DaVita during the 4th quarter worth approximately $55,000. Institutional investors and hedge funds own 90.12% of the company's stock.

DaVita Price Performance

DaVita stock opened at $136.66 on Monday. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20. The company has a market capitalization of $10.32 billion, a PE ratio of 13.54, a price-to-earnings-growth ratio of 0.94 and a beta of 1.11. DaVita Inc. has a one year low of $131.76 and a one year high of $179.60. The business has a 50 day simple moving average of $139.84 and a 200 day simple moving average of $150.02.

DaVita (NYSE:DVA - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $2.00 EPS for the quarter, topping the consensus estimate of $1.75 by $0.25. The business had revenue of $3.22 billion during the quarter, compared to the consensus estimate of $3.22 billion. DaVita had a return on equity of 176.11% and a net margin of 6.63%. DaVita's revenue was up 5.0% on a year-over-year basis. During the same quarter last year, the company earned $2.26 EPS. On average, sell-side analysts forecast that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on DVA shares. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. Truist Financial cut their target price on DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a research report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $164.50.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.